110 related articles for article (PubMed ID: 14649218)
1. CJC-1131. ConjuChem.
Giannoukakis N
Curr Opin Investig Drugs; 2003 Oct; 4(10):1245-9. PubMed ID: 14649218
[TBL] [Abstract][Full Text] [Related]
2. Exenatide. Amylin/Eli Lilly.
Giannoukakis N
Curr Opin Investig Drugs; 2003 Apr; 4(4):459-65. PubMed ID: 12808888
[TBL] [Abstract][Full Text] [Related]
3. SomatoKine. Insmed.
Norman P
Curr Opin Investig Drugs; 2003 Apr; 4(4):466-71. PubMed ID: 12808889
[TBL] [Abstract][Full Text] [Related]
4. Eligen insulin--a system for the oral delivery of insulin for diabetes.
Hoffman A; Qadri B
IDrugs; 2008 Jun; 11(6):433-41. PubMed ID: 18509785
[TBL] [Abstract][Full Text] [Related]
5. DiaPep277 (DeveloGen).
Giannoukakis N
Curr Opin Investig Drugs; 2005 Oct; 6(10):1043-50. PubMed ID: 16259226
[TBL] [Abstract][Full Text] [Related]
6. MK-767. Kyorin/Banyu/Merck.
Calkin AC; Thomas MC; Cooper ME
Curr Opin Investig Drugs; 2003 Apr; 4(4):444-8. PubMed ID: 12808885
[TBL] [Abstract][Full Text] [Related]
7. RDP-58 (SangStat Medical).
Holtmann MM
IDrugs; 2003 Dec; 6(12):1188-94. PubMed ID: 14666431
[TBL] [Abstract][Full Text] [Related]
8. Hematide, a novel peptide-based erythropoiesis-stimulating agent for the treatment of anemia.
Macdougall IC
Curr Opin Investig Drugs; 2008 Sep; 9(9):1034-47. PubMed ID: 18729010
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and tolerability of a novel long-acting glucagon-like peptide-1 analog, CJC-1131, in healthy and diabetic subjects.
Tiessen RG; Castaigne JP; Dreyfus JF; Nemansky M; Kruizinga HH; van Vliet AA
Int J Clin Pharmacol Ther; 2008 Sep; 46(9):443-52. PubMed ID: 18793574
[TBL] [Abstract][Full Text] [Related]
10. Drug evaluation: tesamorelin, a synthetic human growth hormone releasing factor.
Tomlinson B
Curr Opin Investig Drugs; 2006 Oct; 7(10):936-45. PubMed ID: 17086939
[TBL] [Abstract][Full Text] [Related]
11. Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Gallwitz B
IDrugs; 2008 Dec; 11(12):906-17. PubMed ID: 19051153
[TBL] [Abstract][Full Text] [Related]
12. Exendin 4: AC 2993, AC 2993 LAR.
BioDrugs; 2002; 16(3):220-2. PubMed ID: 12102651
[No Abstract] [Full Text] [Related]
13. BIM-51077, a dipeptidyl peptidase-IV-resistant glucagon-like peptide-1 analog.
Giannoukakis N
Curr Opin Investig Drugs; 2007 Oct; 8(10):842-8. PubMed ID: 17907061
[TBL] [Abstract][Full Text] [Related]
14. CLX-0901 (Calyx Therapeutics).
Barlocco D
Curr Opin Investig Drugs; 2001 May; 2(5):650-3. PubMed ID: 11569941
[TBL] [Abstract][Full Text] [Related]
15. Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: focus on sitagliptin.
Herman GA; Stein PP; Thornberry NA; Wagner JA
Clin Pharmacol Ther; 2007 May; 81(5):761-7. PubMed ID: 17392725
[TBL] [Abstract][Full Text] [Related]
16. [Exenatide (Byetta)].
Duh D; Vandevijver A
J Pharm Belg; 2008 Mar; 63(1):29-30. PubMed ID: 18479081
[No Abstract] [Full Text] [Related]
17. Molecule of the month. Exenatide.
Drug News Perspect; 2003 Nov; 16(9):621. PubMed ID: 14702143
[No Abstract] [Full Text] [Related]
18. ALX-0600 (NPS Allelix Corp).
Sigalet DL
Curr Opin Investig Drugs; 2001 Apr; 2(4):505-9. PubMed ID: 11566007
[TBL] [Abstract][Full Text] [Related]
19. [Incretin-mimetic drugs, an insulin alternative in type 2 diabetes].
Fabreegas B
Soins; 2008 Jun; (726):34-7. PubMed ID: 18697336
[No Abstract] [Full Text] [Related]
20. Drug evaluation: PSN-9301, a short-acting inhibitor of dipeptidyl peptidase IV.
Epstein BJ
Curr Opin Investig Drugs; 2007 Apr; 8(4):331-7. PubMed ID: 17458184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
